<DOC>
	<DOCNO>NCT00722241</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness next-generation DexCom SEVEN Continuous Glucose Monitoring System ( SEVEN.2 System ) wear 7-days subject &gt; 18 years-old diabetes mellitus require insulin therapy .</brief_summary>
	<brief_title>Effectiveness Safety Study Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Age 18 year old Have diagnose insulinrequiring diabetes multiple daily injection ( MDI ) Continuous Subcutaneous Insulin Infusion ( CSII ) insulin therapy Willing inject insulin wear insulin pump insertion set within 3 inch Sensor site Sensor wear Willing use blood glucose meter ( ) provide selfmonitoring blood glucose ( SMBG ) Sensor wear Willing participate one , 8hour inclinic session willing take 4 fingersticks per hour 4 blood draw per hour entire 8hour duration Willing take minimum 6 fingersticks per day home use ( 2 calibration purpose , 4 comparative purpose ) Willing refrain use acetaminophen Sensor insertion period least 24hours prior Sensor insertion Willing schedule magnetic resonance ( MRI ) scan , compute tomography ( CT ) scan , xray , duration study Able speak , read , write English Have extensive skin changes/diseases preclude wear Sensor normal skin ( e.g . extensive psoriasis , recent burn severe sunburn , extensive eczema , extensive scarring , extensive tattoo , dermatitis herpetiformis ) propose wear site Subjects know allergy medicalgrade adhesive Are pregnant demonstrated positive pregnancy test within 72 hour insertion Have hematocrit less 30 % , great 55 % Current participation another investigational study protocol ( subject recently complete participation another drug study , subject must complete study least 30 day prior enrol study ) Have condition , opinion Investigator , would interfere participation trial pose excessive risk study staff handle venous blood sample ( e.g. , known history hepatitis B C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Continuous Glucose Monitoring</keyword>
	<keyword>Interstitial Fluid</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>